GianPietro Sechi

GianPietro Sechi

orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2007 in The Lancet Neurology
Verified
Journal Article
Closed access
GSGianPietro Sechi
GianPietro Sechi
ASAlessandro Serra
Alessandro Serra

30 March 2016 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
GSGianPietro Sechi
GianPietro Sechi
ESElia Sechi
Elia Sechi
CFChiara Fois
Chiara Fois
NKNeeraj Kumar
Neeraj Kumar
B vitamin deficiency is a leading cause of neurological impairment and disability throughout the world. Multiple B vitamin deficiencies often coexist, and thus an understanding of the complex relationships between the different biochemical pathways regulated in the brain by these vitamins may facilitate prompter diagnosis and improved treatment. Particular populations at risk for multiple B vitamin deficiencies include the elderly, people with alcoholism, patients with heart failure, patients with recent obesity surgery, and vegetarians/vegans. Recently, new clinical settings that predispose individuals to B vitamin deficiency have been highlighted. Moreover, other data indicate a possible pathogenetic role of subclinical chronic B vitamin deficiency in neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. In light of these findings, this review examines the clinical manifestations of B vitamin deficiency and the effect of B vitamin deficiency on the adult nervous system. The interrelationships of multiple B vitamin deficiencies are emphasized, along with the clinical phenotypes related to B vitamin deficiencies. Recent advances in the clinical determinants and diagnostic clues of B vitamin deficiency, as well as the suggested therapies for B vitamin disorders, are described.

7 October 2013 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
PRPaolo Ruzza
Paolo Ruzza
GSGiuliano Siligardi
Giuliano Siligardi
RHRohanah Hussain
Rohanah Hussain
AMAnna Marchiani
Anna Marchiani
MIMehmet Islami
Mehmet Islami
GSGianPietro Sechi
GianPietro Sechi

31 March 2018 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
GAG. Arru
G. Arru
GMG. Mameli
G. Mameli
GDG. A. Deiana
G. A. Deiana
ARA. L. Rassu
A. L. Rassu
RPR. Piredda
R. Piredda
Leonardo SechiLeonardo Sechi
Leonardo Sechi

1 March 2008 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
GSGianPietro Sechi
GianPietro Sechi
VAVirgilio Agnetti
Virgilio Agnetti
PGPaola Galistu
Paola Galistu
BMBastianino Murgia
Bastianino Murgia
FMFrancesco Marrosu
Francesco Marrosu
KPKai Stephan Paulus
Kai Stephan Paulus

23 August 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
GAGiannina Arru
Giannina Arru
Grazia GalleriGrazia Galleri
Grazia Galleri
GDGiovanni A. Deiana
Giovanni A. Deiana
IZIgnazio Roberto Zarbo
Ignazio Roberto Zarbo
ESElia Sechi
Elia Sechi
Leonardo SechiLeonardo Sechi
Leonardo Sechi
Human endogenous retrovirus (HERV)-K env-su glycoprotein has been documented in amyotrophic lateral sclerosis (ALS), where HERV-K env-su 19–37 antibody levels significantly correlated with clinical measures of disease severity. Herein, we investigated further the humoral and cell-mediated immune response against specific antigenic peptides derived from HERV-K in ALS. HERV-K env glycoprotein expression on peripheral blood mononuclear cells (PBMCs) membrane and cytokines and chemokines after stimulation with HERV-K env 19–37 and HERV-K env 109–126 were quantified in patients and healthy controls (HCs). HERV-K env glycoprotein was more expressed in B cells and NK cells of ALS patients compared to HCs, whereas HERV-K env transcripts were similar in ALS and HCs. In ALS patients, specific stimulation with HERV-K env 109–126 peptide showed a higher expression of IL-6 by CD19/B cells. Both peptides, however, were able to induce a great production of IFN-γ by stimulation CD19/B cells, and yielded a higher expression of MIP-1α and a lower expression of MCP-1. HERV-K env 19–37 peptide induced a great production of TNF-α in CD8/T cells. In conclusion, we observed the ability of HERV-K to modulate the immune system, generating mediators mainly involved in proinflammatory response.